Trinity Biotech earnings were -$36.5M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest TRIB earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRIB reported annual earnings of -$31.8M, with 32.4% growth.
What were Trinity Biotech's earnings last quarter?
Trinity Biotech (NASDAQ: TRIB) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total TRIB earnings for the quarter were N/A. In the same quarter last year, Trinity Biotech's earnings per share (EPS) was N/A.
As of the last Trinity Biotech earnings report, Trinity Biotech is currently losing money. Trinity Biotech's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$36.48 million, a 63.61% increase year over year.
What was TRIB's earnings growth in the past year?
As of Trinity Biotech's earnings date in Q1 2026, Trinity Biotech's earnings has grown year over year. TRIB earnings in the past year totalled -$36.48 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.